Dr. Isabella C. Glitza, MD
Claim this profileM D Anderson Cancer Center
Studies Skin Cancer
Studies Cutaneous Melanoma
3 reported clinical trials
5 drugs studied
Area of expertise
1Skin Cancer
Stage IV
BRAF positive
PD-L1 negative
2Cutaneous Melanoma
Stage IV
BRAF positive
PD-L1 negative
Affiliated Hospitals
Clinical Trials Isabella C. Glitza, MD is currently running
Binimetinib + Encorafenib
for Melanoma
This trial studies how well binimetinib and encorafenib work in patients with melanoma that has spread to the brain. These medications may help stop cancer growth by blocking important enzymes. The trial focuses on patients with a specific mutation (BRAFV600) whose cancer has spread to critical areas. Encorafenib and binimetinib are FDA-approved for treating metastatic melanoma with BRAFV600 mutations.
Recruiting1 award Phase 222 criteria
Intravenous and Intrathecal Nivolumab
for Leptomeningeal Disease
This phase I/Ib trial studies the side effects and best dose of intrathecal nivolumab, and how well it works in combination with intravenous nivolumab in treating patients with leptomeningeal disease. Immunotherapy with monoclonal antibodies, such as nivolumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread.
Recruiting2 awards Phase 116 criteria
More about Isabella C. Glitza, MD
Clinical Trial Related3 years of experience running clinical trials · Led 3 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments Isabella C. Glitza, MD has experience with
- Ipilimumab
- Pembrolizumab
- Binimetinib
- Encorafenib
- Nivolumab
Breakdown of trials Isabella C. Glitza, MD has run
Skin Cancer
Cutaneous Melanoma
Melanoma
Brain Metastasis
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Isabella C. Glitza, MD specialize in?
Isabella C. Glitza, MD focuses on Skin Cancer and Cutaneous Melanoma. In particular, much of their work with Skin Cancer has involved Stage IV patients, or patients who are BRAF positive.
Is Isabella C. Glitza, MD currently recruiting for clinical trials?
Yes, Isabella C. Glitza, MD is currently recruiting for 2 clinical trials in Houston Texas. If you're interested in participating, you should apply.
Are there any treatments that Isabella C. Glitza, MD has studied deeply?
Yes, Isabella C. Glitza, MD has studied treatments such as Ipilimumab, Pembrolizumab, Binimetinib.
What is the best way to schedule an appointment with Isabella C. Glitza, MD?
Apply for one of the trials that Isabella C. Glitza, MD is conducting.
What is the office address of Isabella C. Glitza, MD?
The office of Isabella C. Glitza, MD is located at: M D Anderson Cancer Center, Houston, Texas 77030 United States. This is the address for their practice at the M D Anderson Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.